Publication | Open Access
Silibinin Inhibits LPS-Induced Macrophage Activation by Blocking p38 MAPK in RAW 264.7 Cells
62
Citations
35
References
2013
Year
P38 Mapk SignalingImmunologyP38 MapkInflammationMolecular PharmacologySignaling PathwayAutophagyP38 Mapk InhibitorMetabolic SignalingCell SignalingMolecular SignalingMolecular PathwayPharmacologyCell BiologyRaw 264.7Protein PhosphorylationPhagocyteCytokineSignal TransductionMedicineDrug Discovery
We demonstrate herein that silibinin, a polyphenolic flavonoid compound isolated from milk thistle (Silybum marianum), inhibits LPS-induced activation of macrophages and production of nitric oxide (NO) in RAW 264.7 cells. Western blot analysis showed silibinin inhibits iNOS gene expression. RT-PCR showed that silibinin inhibits iNOS, TNF-α, and IL1β. We also showed that silibinin strongly inhibits p38 MAPK phosphorylation, whereas the ERK1/2 and JNK pathways are not inhibited. The p38 MAPK inhibitor abrogated the LPS-induced nitrite production, whereas the MEK-1 inhibitor did not affect the nitrite production. A molecular modeling study proposed a binding pose for silibinin targeting the ATP binding site of p38 MAPK (1OUK). Collectively, this series of experiments indicates that silibinin inhibits macrophage activation by blocking p38 MAPK signaling.
| Year | Citations | |
|---|---|---|
Page 1
Page 1